UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000029914 |
|---|---|
| Receipt number | R000034171 |
| Scientific Title | The efficacy of Quadratus Lumborum Block as a postoperative analgesia for Total Hip Arthroplasty. |
| Date of disclosure of the study information | 2017/11/14 |
| Last modified on | 2021/08/07 15:27:27 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The efficacy of Quadratus Lumborum Block as a postoperative analgesia for Total Hip Arthroplasty.
Acronym
The efficacy of Quadratus Lumborum Block as a postoperative analgesia for Total Hip Arthroplasty.
Scientific Title
The efficacy of Quadratus Lumborum Block as a postoperative analgesia for Total Hip Arthroplasty.
Scientific Title:Acronym
The efficacy of Quadratus Lumborum Block as a postoperative analgesia for Total Hip Arthroplasty.
Region
| Japan |
Condition
Condition
Hip osteoarthritis
Classification by specialty
| Orthopedics |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The strength maintenance of Hip joint after Quadratus Lumborum Block(QLB).
Basic objectives2
Others
Basic objectives -Others
Analgesic effect in postoperative period.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The muscle strength of hip flexion using by hand held dynamometer 6 hours after total hip arthroplasty.
Key secondary outcomes
Postoperative analgesic scores (0,6,12,24,48 hours), The muscle strength of hip flexion using by hand held dynamometer(0,12,24,48 hours), Complications. The effective are of QLB.
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Maneuver |
Interventions/Control_1
QLB
Interventions/Control_2
Lumber Plexus Block(LPB)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 75 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Initial total hip arthroplasty.
Key exclusion criteria
Blood platelet disorder, Coagulation intolerance. Difficulty to have a communicate.
Target sample size
58
Research contact person
Name of lead principal investigator
| 1st name | Takafumi |
| Middle name | |
| Last name | Iida |
Organization
Asahikawa Medical University
Division name
Anesthesiology and Critical Care Medicine
Zip code
0788510
Address
Midorigaoka-higashi 2-1-1-1,Asahikawa,Hokkaido,Japan
TEL
0166682583
takka1845@fg7.so-net.ne.jp
Public contact
Name of contact person
| 1st name | Takafumi |
| Middle name | |
| Last name | Iida |
Organization
Asahikawa Medical University
Division name
Anesthesiology and Critical Care Medicine
Zip code
0788510
Address
Midorigaoka-higashi 2-1-1-1,Asahikawa,Hokkaido,Japan
TEL
0166682583
Homepage URL
takka1845@fg7.so-net.ne.jp
Sponsor or person
Institute
Asahikawa medical university
Institute
Department
Personal name
Funding Source
Organization
Department of Anesthesiology and critical care medicine ,Asahikawa medical university
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Asahikawa Medical University
Address
Midorigaoka-higashi 2-1-1-1,Asahikawa,Hokkaido,Japan
Tel
0166682583
pikaseika@jimu.asahikawa-med.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 11 | Month | 14 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2017 | Year | 09 | Month | 22 | Day |
Date of IRB
| 2017 | Year | 11 | Month | 10 | Day |
Anticipated trial start date
| 2017 | Year | 11 | Month | 20 | Day |
Last follow-up date
| 2021 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2017 | Year | 11 | Month | 10 | Day |
Last modified on
| 2021 | Year | 08 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034171
